“…Mutations in the p97 gene have been associated with the development of multisystem proteinopathy (MSP) in humans, with the pathological accumulation of protein aggregates in the brain, muscle, and bone [ 25 , 26 , 27 , 28 ]. p97 has also been identified as a target for the treatment of cancer and neurological, viral, and parasitic diseases [ 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ]. p97 assembles as a homohexamer with a quaternary structure in the shape of a double-stacked ring in the absence of a substrate [ 14 , 37 ].…”